Company / FCF Margin
Rani Therapeutics Holdings, Inc. FCF Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-3479.0%
FY2025
5-year range
-3497.8% / -1205.4%
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-3479.0% in FY2025.
Remained stable around -3479.0% over the past 4 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -2273.6pp
- 5-Year Change
- -
- 10-Year Change
- -
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -3479.0% | - |
| FY2024 | - | - |
| FY2022 | -1205.4% | +65.5% |
| FY2021 | -3497.8% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026